Safa Tahmasebi

2.8k citations
59 papers · 1.9k indexed · 3 hit papers · h-index 21

Safa Tahmasebi

51 papers receiving 1.8k citations

Hit Papers

Exosome engineering in cell therapy and drug delivery2122021202620222024100200300

Peers

Safa Tahmasebi
Comparison fields: 5 of 125
  • Oncology 815
  • Immunology 555
  • Cancer Research 205
  • Infectious Diseases 221
  • Molecular Medicine 51
Replace Navid Shomali with:
Navid Shomali Iran
Raffaele Strippoli Italy
Kiseok Jang South Korea
Hao Chen China
Chian‐Shiu Chien Taiwan
Yan Geng China
Roza Motavalli Iran
Fabrice Journé Belgium
Zaoqu Liu China
Safa Tahmasebi relative to Navid Shomali Iran Navid Shomali's profile →
Citations per field
00.5×4.3×
Navid Shomali · 1×
Citations per year

Countries citing papers authored by Safa Tahmasebi

Since Specialization
Citations

This map shows the geographic impact of Safa Tahmasebi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Safa Tahmasebi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Safa Tahmasebi more than expected).

Fields of papers citing papers by Safa Tahmasebi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Safa Tahmasebi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Safa Tahmasebi. The network helps show where Safa Tahmasebi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Safa Tahmasebi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Safa Tahmasebi Line = papers co-authored together Safa Tahmasebi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20250
4 20251
5 20250
6 20253
7 20251
8 20250
9 20250
10 20256
11 20242
12 20237
13 2022104
14 20212
15 202118
16 202117
17 202116
18 20214
19 2020127
20 201943

About Safa Tahmasebi

Safa Tahmasebi is a scholar working on Aging, Immunology and Oncology, having authored 59 papers that have together received 1.9k indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (10 papers), SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (7 papers), Virus-based gene therapy research (6 papers), Cancer-related molecular mechanisms research (5 papers), Nanowire Synthesis and Applications (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Oncology (815 citations), Immunology (555 citations) and Cancer Research (205 citations). Safa Tahmasebi has collaborated with scholars based in Iran, United States and Russia. Frequent co-authors include Abdolreza Esmaeilzadeh, Reza Elahi, Seyed Mahmoud Hashemi, Fahimeh Ramezani Tehrani, Somayeh Sadeghi, Abbas Shafiee, Faroogh Marofi, Alexei Valerievich Yumashev, Mostafa Jarahian and Yashwant Pathak. Their work appears in journals such as Cancer Cell International, Stem Cell Research & Therapy, Clinical and Experimental Medicine, Life Sciences and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026